This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The blepharoplasty market size has grown strongly in recent years. It will grow from $4.2 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to aesthetic preferences and beauty standards, aging population demographics, increased awareness and acceptance, media, and celebrity influence.
The blepharoplasty market size is expected to see strong growth in the next few years. It will grow to $6.28 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising disposable income, cultural and social factors, customization of procedures, medical tourism, and accessibility. Major trends in the forecast period include focus on natural and youthful results, integration of technology for precision and safety, emergence of combination procedures, increased demand for ethnic-specific blepharoplasty, growing role of non-surgical alternatives.
The rising demand for cosmetic surgeries is anticipated to drive the growth of the blepharoplasty market in the future. Cosmetic surgeries are medical procedures conducted to enhance or modify an individual's physical appearance for aesthetic reasons. Procedures like blepharoplasty enable individuals to improve the look of their eyelids and address concerns with the upper eyelids, including excess skin, drooping skin (dermatochalasis), and fat deposits that cause a puffy appearance. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, reflecting a total increase of 11.2%. Thus, the growing demand for cosmetic surgeries is set to boost the expansion of the blepharoplasty market.
The increasing prevalence of renal disease is forecasted to drive growth within the blepharoplasty market moving forward. Renal disease, also known as chronic kidney disease (CKD), involves the gradual loss of kidney function. This medical condition can manifest in symptoms such as eye puffiness and altered eyelid positions, potentially affecting individuals considering blepharoplasty surgery. Notably, patients with renal disease should undergo renal function assessments before opting for blepharoplasty procedures. As highlighted by the National Institutes of Health in May 2023, approximately 808,000 individuals in the United States are currently managing end-stage renal disease (ESRD), with 69% undergoing dialysis and 31% having received a kidney transplant. This prevalence of renal disease contributes to the increased demand for blepharoplasty, driving growth within the market catering to such medical needs.
Leading companies operating within the blepharoplasty market are strategically prioritizing the development of cutting-edge technologies, such as plasma technology, to strengthen their market position. Plasma technology involves utilizing ionized gases (plasmas) through specialized medical devices for non-surgical skin tightening and rejuvenation, particularly in areas such as the eyelids and facial regions. For example, in January 2023, Apyx Medical Corporation, a renowned US-based advanced energy technology company, introduced the latest-generation Renuvion generator, named the Apyx One Console. This multifunctional energy system is tailored for plastic and cosmetic surgeries, integrating Renuvion technology comprising helium plasma and radiofrequency technology, alongside monopolar and bipolar energy options. The console incorporates adaptive touchscreens, procedural presets, cloud connectivity, remote upgrade capabilities, gas volume monitoring, and other advanced features aimed at enhancing cosmetic surgical procedures, including eyelid surgery, thereby paving the way for more effective and advanced treatment options in the market.
In February 2023, Athenix, a prominent US-based medical practice company specializing in plastic surgery procedures, completed the acquisition of Marina Plastic Surgery and MedSpa for an undisclosed sum. This strategic move by Athenix is geared towards broadening its footprint within the plastic surgery sector while enhancing its range of services. The acquisition aligns with Athenix's strategic goals of expanding its offerings and strengthening its position in the plastic surgery industry. By integrating Marina Plastic Surgery and MedSpa into its portfolio, Athenix aims to reinforce its commitment to delivering comprehensive and innovative plastic surgery solutions. This strategic acquisition further solidifies Athenix's reputation as a trusted and reputable provider in the industry. Marina Plastic Surgery and MedSpa, the acquired entity, specializes in providing plastic surgery services, with a particular focus on offering blepharoplasty procedures.
Major companies operating in the blepharoplasty market report are Zimmer Biomet Holdings Inc., Cynosure Technologies Pvt Ltd., Galderma SA, Bausch & Lomb Incorporated., Allergan Inc., Integra LifeSciences Inc., Merz Pharma GmbH & Co. KGaA, Corza Ophthalmology, Lumenis Ltd., Cutera Inc., Stille AB, Alma Lasers Ltd., Sciton Inc., Beaver-Visitec International Holdings Inc., Sklar Surgical Instruments, Hayden Medical Inc., Gulmaher Surgico, Titan Medical Inc., Luminera Derm Ltd., Jedmed Instrument Company., Xelpov Surgical, Surgitrac Instruments UK Limited, Grand Aespio Inc., Surgical Holdings, Surgipro Inc., LightScalpel Inc., SPIRAL Surgical Co., Carnegie Surgical LLC., Ambler Surgical LLC.
North America was the largest region in the blepharoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blepharoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blepharoplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The blepharoplasty market consists of revenues earned by entities by providing transconjunctival blepharoplasty, canthoplasty, and revision blepharoplasty. The market value includes the value of related goods sold by the service provider or included within the service offering. The blepharoplasty market also includes sales of implants, eyelid cleansers and solutions, eyelid tape, and strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Blepharoplasty is a surgical procedure designed to enhance the aesthetics of the eyelids by eliminating surplus skin, muscle, and fat from both the upper and lower eyelids. This surgery serves dual purposes, addressing cosmetic concerns and functional issues related to impaired vision caused by drooping eyelids.
The primary types of blepharoplasty include upper eyelid blepharoplasty, lower eyelid blepharoplasty, and combination eyelid surgery. Upper eyelid blepharoplasty involves the surgical removal of excess skin, muscle, and fat from the upper eyelids, resulting in a rejuvenated appearance by eliminating redundant tissue and creating a more refreshed look. Blepharoplasty procedures are conducted on individuals of both genders, with end-users comprising hospitals, clinics, ambulatory surgical centers, and other medical facilities.
The blepharoplasty market research report is one of a series of new reports that provides blepharoplasty market statistics, including blepharoplasty industry global market size, regional shares, competitors with a blepharoplasty market share, detailed blepharoplasty market segments, market trends and opportunities, and any further data you may need to thrive in the blepharoplasty industry. This blepharoplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The blepharoplasty market size has grown strongly in recent years. It will grow from $4.2 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to aesthetic preferences and beauty standards, aging population demographics, increased awareness and acceptance, media, and celebrity influence.
The blepharoplasty market size is expected to see strong growth in the next few years. It will grow to $6.28 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising disposable income, cultural and social factors, customization of procedures, medical tourism, and accessibility. Major trends in the forecast period include focus on natural and youthful results, integration of technology for precision and safety, emergence of combination procedures, increased demand for ethnic-specific blepharoplasty, growing role of non-surgical alternatives.
The rising demand for cosmetic surgeries is anticipated to drive the growth of the blepharoplasty market in the future. Cosmetic surgeries are medical procedures conducted to enhance or modify an individual's physical appearance for aesthetic reasons. Procedures like blepharoplasty enable individuals to improve the look of their eyelids and address concerns with the upper eyelids, including excess skin, drooping skin (dermatochalasis), and fat deposits that cause a puffy appearance. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, reflecting a total increase of 11.2%. Thus, the growing demand for cosmetic surgeries is set to boost the expansion of the blepharoplasty market.
The increasing prevalence of renal disease is forecasted to drive growth within the blepharoplasty market moving forward. Renal disease, also known as chronic kidney disease (CKD), involves the gradual loss of kidney function. This medical condition can manifest in symptoms such as eye puffiness and altered eyelid positions, potentially affecting individuals considering blepharoplasty surgery. Notably, patients with renal disease should undergo renal function assessments before opting for blepharoplasty procedures. As highlighted by the National Institutes of Health in May 2023, approximately 808,000 individuals in the United States are currently managing end-stage renal disease (ESRD), with 69% undergoing dialysis and 31% having received a kidney transplant. This prevalence of renal disease contributes to the increased demand for blepharoplasty, driving growth within the market catering to such medical needs.
Leading companies operating within the blepharoplasty market are strategically prioritizing the development of cutting-edge technologies, such as plasma technology, to strengthen their market position. Plasma technology involves utilizing ionized gases (plasmas) through specialized medical devices for non-surgical skin tightening and rejuvenation, particularly in areas such as the eyelids and facial regions. For example, in January 2023, Apyx Medical Corporation, a renowned US-based advanced energy technology company, introduced the latest-generation Renuvion generator, named the Apyx One Console. This multifunctional energy system is tailored for plastic and cosmetic surgeries, integrating Renuvion technology comprising helium plasma and radiofrequency technology, alongside monopolar and bipolar energy options. The console incorporates adaptive touchscreens, procedural presets, cloud connectivity, remote upgrade capabilities, gas volume monitoring, and other advanced features aimed at enhancing cosmetic surgical procedures, including eyelid surgery, thereby paving the way for more effective and advanced treatment options in the market.
In February 2023, Athenix, a prominent US-based medical practice company specializing in plastic surgery procedures, completed the acquisition of Marina Plastic Surgery and MedSpa for an undisclosed sum. This strategic move by Athenix is geared towards broadening its footprint within the plastic surgery sector while enhancing its range of services. The acquisition aligns with Athenix's strategic goals of expanding its offerings and strengthening its position in the plastic surgery industry. By integrating Marina Plastic Surgery and MedSpa into its portfolio, Athenix aims to reinforce its commitment to delivering comprehensive and innovative plastic surgery solutions. This strategic acquisition further solidifies Athenix's reputation as a trusted and reputable provider in the industry. Marina Plastic Surgery and MedSpa, the acquired entity, specializes in providing plastic surgery services, with a particular focus on offering blepharoplasty procedures.
Major companies operating in the blepharoplasty market report are Zimmer Biomet Holdings Inc., Cynosure Technologies Pvt Ltd., Galderma SA, Bausch & Lomb Incorporated., Allergan Inc., Integra LifeSciences Inc., Merz Pharma GmbH & Co. KGaA, Corza Ophthalmology, Lumenis Ltd., Cutera Inc., Stille AB, Alma Lasers Ltd., Sciton Inc., Beaver-Visitec International Holdings Inc., Sklar Surgical Instruments, Hayden Medical Inc., Gulmaher Surgico, Titan Medical Inc., Luminera Derm Ltd., Jedmed Instrument Company., Xelpov Surgical, Surgitrac Instruments UK Limited, Grand Aespio Inc., Surgical Holdings, Surgipro Inc., LightScalpel Inc., SPIRAL Surgical Co., Carnegie Surgical LLC., Ambler Surgical LLC.
North America was the largest region in the blepharoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blepharoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blepharoplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The blepharoplasty market consists of revenues earned by entities by providing transconjunctival blepharoplasty, canthoplasty, and revision blepharoplasty. The market value includes the value of related goods sold by the service provider or included within the service offering. The blepharoplasty market also includes sales of implants, eyelid cleansers and solutions, eyelid tape, and strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Blepharoplasty is a surgical procedure designed to enhance the aesthetics of the eyelids by eliminating surplus skin, muscle, and fat from both the upper and lower eyelids. This surgery serves dual purposes, addressing cosmetic concerns and functional issues related to impaired vision caused by drooping eyelids.
The primary types of blepharoplasty include upper eyelid blepharoplasty, lower eyelid blepharoplasty, and combination eyelid surgery. Upper eyelid blepharoplasty involves the surgical removal of excess skin, muscle, and fat from the upper eyelids, resulting in a rejuvenated appearance by eliminating redundant tissue and creating a more refreshed look. Blepharoplasty procedures are conducted on individuals of both genders, with end-users comprising hospitals, clinics, ambulatory surgical centers, and other medical facilities.
The blepharoplasty market research report is one of a series of new reports that provides blepharoplasty market statistics, including blepharoplasty industry global market size, regional shares, competitors with a blepharoplasty market share, detailed blepharoplasty market segments, market trends and opportunities, and any further data you may need to thrive in the blepharoplasty industry. This blepharoplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Blepharoplasty Market Characteristics3. Blepharoplasty Market Trends and Strategies4. Blepharoplasty Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Covid and Recovery on the Market32. Global Blepharoplasty Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Blepharoplasty Market34. Recent Developments in the Blepharoplasty Market
5. Global Blepharoplasty Growth Analysis and Strategic Analysis Framework
6. Blepharoplasty Market Segmentation
7. Blepharoplasty Market Regional and Country Analysis
8. Asia-Pacific Blepharoplasty Market
9. China Blepharoplasty Market
10. India Blepharoplasty Market
11. Japan Blepharoplasty Market
12. Australia Blepharoplasty Market
13. Indonesia Blepharoplasty Market
14. South Korea Blepharoplasty Market
15. Western Europe Blepharoplasty Market
16. UK Blepharoplasty Market
17. Germany Blepharoplasty Market
18. France Blepharoplasty Market
19. Italy Blepharoplasty Market
20. Spain Blepharoplasty Market
21. Eastern Europe Blepharoplasty Market
22. Russia Blepharoplasty Market
23. North America Blepharoplasty Market
24. USA Blepharoplasty Market
25. Canada Blepharoplasty Market
26. South America Blepharoplasty Market
27. Brazil Blepharoplasty Market
28. Middle East Blepharoplasty Market
29. Africa Blepharoplasty Market
30. Blepharoplasty Market Competitive Landscape and Company Profiles
31. Blepharoplasty Market Other Major and Innovative Companies
35. Blepharoplasty Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Blepharoplasty Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on blepharoplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blepharoplasty? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blepharoplasty market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Upper Eyelid Blepharoplasty; Lower Eyelid Blepharoplasty; Combination Eyelid Surgery2) By Gender: Female; Male
3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centre; Other End-Users
Subsegments:
1) By Upper Eyelid Blepharoplasty: Traditional Upper Eyelid Surgery; Laser Upper Eyelid Surgery2) By Lower Eyelid Blepharoplasty: Transconjunctival Lower Eyelid Surgery; Traditional Lower Eyelid Surgery
3) By Combination Eyelid Surgery: Upper And Lower Eyelid Surgery Together; Eyelid Surgery With Other Facial Procedures
Key Companies Mentioned: Zimmer Biomet Holdings Inc.; Cynosure Technologies Pvt Ltd.; Galderma SA; Bausch & Lomb Incorporated.; Allergan Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Blepharoplasty market report include:- Zimmer Biomet Holdings Inc.
- Cynosure Technologies Pvt Ltd.
- Galderma SA
- Bausch & Lomb Incorporated.
- Allergan Inc
- Integra LifeSciences Inc.
- Merz Pharma GmbH & Co. KGaA
- Corza Ophthalmology
- Lumenis Ltd.
- Cutera Inc.
- Stille AB
- Alma Lasers Ltd
- Sciton Inc
- Beaver-Visitec International Holdings Inc.
- Sklar Surgical Instruments
- Hayden Medical Inc
- Gulmaher Surgico
- Titan Medical Inc.
- Luminera Derm Ltd
- Jedmed Instrument Company.
- Xelpov Surgical
- Surgitrac Instruments UK Limited
- Grand Aespio Inc.
- Surgical Holdings
- Surgipro Inc.
- LightScalpel Inc.
- SPIRAL Surgical Co.
- Carnegie Surgical LLC.
- Ambler Surgical LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 4.55 Billion |
| Forecasted Market Value ( USD | $ 6.28 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
